SA
CLX icon

Sicart Associates’s Clorox CLX Stock Holding History

Sicart Associates’s Portfolio CLX Stock Details CLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-14,435
Closed -$1.5M – 75
2026
Q1 		$1.5M Sell
14,435
-770
-5% -$87.3K 0.38% 43
2025
Q4 		$1.53M Sell
15,205
-7,140
-32% -$775K 0.41% 41
2025
Q3 		$2.76M Hold
22,345
– – 0.75% 37
2025
Q2 		$2.68M Sell
22,345
-930
-4% -$124K 0.94% 35
2025
Q1 		$3.43M Sell
23,275
-10
-0% -$1.53K 1.19% 32
2024
Q4 		$3.78M Sell
23,285
-1,240
-5% -$203K 1.35% 30
2024
Q3 		$4M Hold
24,525
– – 1.4% 30
2024
Q2 		$3.35M Sell
24,525
-605
-2% -$84K 1.28% 32
2024
Q1 		$3.85M Sell
25,130
-460
-2% -$68.7K 1.41% 26
2023
Q4 		$3.65M Sell
25,590
-1,280
-5% -$171K 1.4% 27
2023
Q3 		$3.52M Buy
26,870
+1,103
+4% +$168K 1.38% 26
2023
Q2 		$4.1M Buy
25,767
+470
+2% +$75.8K 1.59% 24
2023
Q1 		$4M Sell
25,297
-3,420
-12% -$513K 1.56% 27
2022
Q4 		$4.03M Buy
28,717
+475
+2% +$67.4K 1.42% 26
2022
Q3 		$3.63M Sell
28,242
-205
-0.7% -$29.6K 1.29% 29
2022
Q2 		$4.01M Sell
28,447
-2,570
-8% -$367K 1.25% 28
2022
Q1 		$4.31M Sell
31,017
-40
-0.1% -$6.13K 1.12% 31
2021
Q4 		$5.35M Buy
31,057
+775
+3% +$129K 1.4% 24
2021
Q3 		$5.01M Buy
+30,282
New +$5.21M 1.37% 27

Other funds holding CLX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Sicart Associates's CLX Position: Q2 2026 in Review

Sicart Associates sold out of Clorox (CLX) in Q2 2026, closing a stake of 14,435 shares — an estimated $1.5M sold.

Sicart Associates first reported a position in CLX in Q3 2021 and held it in 19 quarters. The position peaked at $5.35M in Q4 2021. 1,051 funds tracked by Wall St. Rank hold CLX as of Q2 2026.

  • Sicart Associates reported no remaining Clorox position as of Q2 2026 after selling out during the quarter.
  • Sicart Associates sold 14,435 Clorox shares in Q2 2026, an estimated $1.5M.
  • Sicart Associates first reported a position in Clorox in Q3 2021 and held it in 19 quarters.
  • Sicart Associates's Clorox position peaked at $5.35M in Q4 2021.
  • 1,051 funds tracked by Wall St. Rank held Clorox as of Q2 2026.

Based on Sicart Associates's 13F filing for Q2 2026, filed 11 Aug 2026.